Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 111
Filter
1.
Braz. J. Pharm. Sci. (Online) ; 59: e21328, 2023. tab, graf
Article in English | LILACS | ID: biblio-1439548

ABSTRACT

Abstract The present study entails the systematic development and validation of a stability-indicating RP-HPLC method for the analysis of sitagliptin and ertugliflozin in a fixed-dose combination. Analytical quality by design (AQbD) concepts were used to define critical method variables, employing Pareto risk assessment and a Placket-Burman screening design, preceded by a Box-Behnken design with response surface analysis to optimise critical method parameters such as % acetonitrile (X1), buffer pH (X2) and column oven temperature (X3). Multiple response optimisation (Derringer's desirability) of variables was accomplished by studying critical analytical attributes, such as resolution, retention time and theoretical plates. The title analytes were separated effectively on a PRONTOSIL C18 column at 37 °C using a mobile phase of acetonitrile:acetate buffer, pH 4.4 (36:64 percent v/v), pumped at a flow rate of 1 mL/min, and UV detection at 225 nm. Linearity was observed over a concentration range of 25-150 µg/mL and 3.75-22.5 µg/mL at retention times of 2.82 and 3.92 min for sitagliptin and ertugliflozin, respectively. The method obeyed all validation parameters of the ICH Q2(R1) guidelines. The proposed robust method allows the study of the selected drugs in pharmaceutical dosage forms as well as in drug stability studies under various stress conditions.


Subject(s)
Drawing , Sitagliptin Phosphate/analysis , Pharmaceutical Preparations/administration & dosage , Chromatography, High Pressure Liquid/methods , Total Quality Management/classification , Hydrogen-Ion Concentration/drug effects
2.
Biochem Pharmacol ; 177: 113940, 2020 07.
Article in English | MEDLINE | ID: mdl-32224135

ABSTRACT

Proton pump inhibitors (PPI) are suppressors of gastric acid secretion (SGAS) that decrease gastric nitric oxide (NO) formation from nitrite and increase the cardiovascular risk. However, H2 receptor antagonists (H2RA) are considered safer than PPIs. We challenged this notion and hypothesized that both omeprazole (PPI) and ranitidine (H2RA) attenuate the responses to oral nitrite because both drugs increase gastric pH and therefore could decrease nitrite-derived NO formation in the stomach. We examined the blood pressure responses to oral nitrite in hypertensive rats treated with omeprazole, ranitidine, or vehicle. Chemiluminensce-based assays were used to measure gastric NO formation, plasma and gastric concentrations of nitrite, nitrate, and nitrosylated species (RXNO) to clarify the mechanism involved in the effects of SGAS on the responses to oral nitrite. Both drugs increased gastric pH, impaired oral nitrite-induced hypotensive responses, gastric NO formation, and blunted the increases in circulating RXNO concentrations, but not in circulating nitrite and nitrate concentrations. These findings were reproduced in a second study using sodium acetate buffers at pH 3.5, 4.5, and 5.5 to mimic gastric pH found with vehicle, ranitidine, and omeprazole, respectively. Increasing gastric pH impaired oral nitrite-induced hypotensive responses, gastric NO formation, and blunted the increases in circulating RXNO concentrations, but not in circulating nitrite and nitrate concentrations. Our results clearly indicate that SGAS impair nitrite-induced gastric formation of NO and vasoactive RXNO in a pH-dependent manner, thus resulting in impaired responses to oral nitrite. These findings may have several clinical implications, particularly to patients with cardiovascular diseases.


Subject(s)
Antihypertensive Agents/administration & dosage , Gastric Acid/chemistry , Gastric Acid/metabolism , Histamine H2 Antagonists/administration & dosage , Hypertension/drug therapy , Omeprazole/administration & dosage , Proton Pump Inhibitors/administration & dosage , Ranitidine/administration & dosage , Sodium Nitrite/administration & dosage , Administration, Oral , Animals , Blood Pressure/drug effects , Disease Models, Animal , Gastric Mucosa/metabolism , Hydrogen-Ion Concentration/drug effects , Male , Nitrates/analysis , Nitrates/blood , Nitric Oxide/analysis , Nitric Oxide/metabolism , Nitrites/analysis , Nitrites/blood , Rats , Rats, Wistar , Treatment Outcome
3.
Rev Gastroenterol Mex (Engl Ed) ; 85(1): 48-55, 2020.
Article in English, Spanish | MEDLINE | ID: mdl-31104856

ABSTRACT

INTRODUCTION/AIM: Levo-pantoprazole, the S-enantiomer of pantoprazole, is a proton pump inhibitor that has been shown in animal studies to be faster and stronger than its racemic formulation. There are no studies on humans and therefore our aim was to evaluate the effects of levo-pantoprazole versus racemic pantoprazole on intragastric pH. MATERIALS AND METHODS: A randomized controlled study was conducted on patients with erosive gastroesophageal reflux disease that were given 20mg of levo-pantoprazole (n = 15) versus 40mg of racemic pantoprazole (n = 15) for 7 days. Baseline and end-of-treatment symptom evaluation and intragastric pH measurement were carried out. RESULTS: There were no differences between the groups in the baseline evaluations. From 40 to 115min after the first dose of levo-pantoprazole, the mean intragastric pH was higher, compared with that of racemic pantoprazole (p < 0.05). After one week, levo-pantoprazole and racemic pantoprazole significantly reduced intragastric acid production and its esophageal exposure (p < 0.05). Even though there was no statistically significant difference, a larger number of patients that received levo-pantoprazole stated that their heartburn improved within the first 3 days. CONCLUSIONS: The S-enantiomer of pantoprazole (levo-pantoprazole) had a faster and stronger effect with respect to acid suppression, compared with its racemic formulation. Although the effect on symptoms was faster with levo-pantoprazole, occurring within the first days of treatment, it was equivalent to that of the racemate at one week of treatment.


Subject(s)
Gastroesophageal Reflux/drug therapy , Hydrogen-Ion Concentration/drug effects , Pantoprazole/chemistry , Pantoprazole/pharmacology , Proton Pump Inhibitors/chemistry , Proton Pump Inhibitors/pharmacology , Adult , Female , Gastroesophageal Reflux/physiopathology , Humans , Male , Middle Aged , Pantoprazole/therapeutic use , Proton Pump Inhibitors/therapeutic use , Time Factors , Treatment Outcome
4.
Mycotoxin Res ; 36(1): 23-30, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31264166

ABSTRACT

The mycotoxin enniatin B1 (ENN B1) is widely present in grain-based feed and food products. In the present study, we have investigated how this lipophilic and ionophoric molecule can affect the lysosomal stability and chaperone-mediated autophagy (CMA) in wild-type (WT) and in lysosome-associated membrane proteins (LAMP)-1/2 double-deficient (DD) mouse embryonic fibroblasts (MEF). The cell viability and lysosomal pH were assessed using the Neutral Red (NR) cytotoxicity assay and the LysoSensor® Yellow/Blue DND-160, respectively. Changes in the expression of the CMA-related components LAMP-2 and the chaperones heat shock cognate (hsc) 70 and heat shock protein (hsp) 90 were determined in cytosolic extracts by immunoblotting. In the NR assay, LAMP-1/2 DD MEF cells were significantly less sensitive to ENN B1 than WT MEF cells after 24 h exposure to ENN B1 at levels of 2.5-10 µmol/L. Exposure to ENN B1 at concentrations below the half maximal effective concentration (EC50) (1.5-1.7 µmol/L) increased the lysosomal pH in WT MEF, but not in LAMP-1/2 DD cells, suggesting that lysosomal LAMP-2 is an early target of ENN B1-induced lysosomal alkalization and cytotoxicity in MEF cells. Additionally, cytosolic hsp90 and LAMP-2 levels slightly increased after exposure for 4 h, indicating lysosomal membrane permeabilization (LMP). In summary, it appeared that ENN B1 can destabilize the LAMP-2 complex in the lysosomal membrane at concentrations close to the EC50, resulting in the alkalinization of lysosomes, partial LMP, and thereby leakage of CMA-associated components into the cytosol.


Subject(s)
Depsipeptides/toxicity , Intracellular Membranes/drug effects , Lysosomes/pathology , Mycotoxins/toxicity , Permeability/drug effects , Animals , Chaperone-Mediated Autophagy/drug effects , Fibroblasts , Gene Deletion , HSC70 Heat-Shock Proteins/drug effects , HSC70 Heat-Shock Proteins/metabolism , HSP90 Heat-Shock Proteins/drug effects , HSP90 Heat-Shock Proteins/metabolism , Hydrogen-Ion Concentration/drug effects , Lysosomal-Associated Membrane Protein 2/drug effects , Lysosomal-Associated Membrane Protein 2/genetics , Lysosomal-Associated Membrane Protein 2/metabolism , Mice , Molecular Chaperones/drug effects , Molecular Chaperones/metabolism
5.
Meat Sci ; 161: 107991, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31710885

ABSTRACT

The bioactive compounds and the antioxidant activity of extracts made with various parts of banana inflorescences (bracts, male flowers, rachis, and whole inflorescence) were evaluated in the first part of this study. The extract made with male flowers (EMF) had a higher content of phenolics and flavonoids, lower IC50 value, and higher FRAP value. Thus, EMF was selected to be used in sausage formulations at the concentrations of 0, 0.5, 1, 1.5, and 2%. The effect of this reformulation on the physicochemical, oxidative, and sensory characteristics of the sausages was evaluated during the refrigerated storage (28 days). EMF presented an effective antioxidant activity, with no major changes on pH, aw, and color parameters. In addition, the sensory quality of the product was not affected by the addition of up to 2% EMF. Therefore, EMF has great potential to be used as a natural antioxidant in meat products.


Subject(s)
Antioxidants/chemistry , Food Quality , Inflorescence/chemistry , Meat Products/analysis , Musa/chemistry , Plant Extracts/chemistry , Pork Meat/analysis , Adult , Animals , Female , Food Storage/methods , Humans , Hydrogen-Ion Concentration/drug effects , Lipid Metabolism/drug effects , Male , Middle Aged , Oxidation-Reduction/drug effects , Swine , Young Adult
6.
World J Gastroenterol ; 25(37): 5578-5589, 2019 Oct 07.
Article in English | MEDLINE | ID: mdl-31602159

ABSTRACT

Helicobacter pylori (H. pylori) is a gram-negative bacterium that infects approximately 4.4 billion individuals worldwide. However, its prevalence varies among different geographic areas, and is influenced by several factors. The infection can be acquired by means of oral-oral or fecal-oral transmission, and the pathogen possesses various mechanisms that improve its capacity of mobility, adherence and manipulation of the gastric microenvironment, making possible the colonization of an organ with a highly acidic lumen. In addition, H. pylori presents a large variety of virulence factors that improve its pathogenicity, of which we highlight cytotoxin associated antigen A, vacuolating cytotoxin, duodenal ulcer promoting gene A protein, outer inflammatory protein and gamma-glutamyl transpeptidase. The host immune system, mainly by means of a Th1-polarized response, also plays a crucial role in the infection course. Although most H. pylori-positive individuals remain asymptomatic, the infection predisposes the development of various clinical conditions as peptic ulcers, gastric adenocarcinomas and mucosa-associated lymphoid tissue lymphomas. Invasive and non-invasive diagnostic methods, each of them with their related advantages and limitations, have been applied in H. pylori detection. Moreover, bacterial resistance to antimicrobial therapy is a major challenge in the treatment of this infection, and new therapy alternatives are being tested to improve H. pylori eradication. Last but not least, the development of effective vaccines against H. pylori infection have been the aim of several research studies.


Subject(s)
Gastric Mucosa/microbiology , Helicobacter Infections/therapy , Helicobacter pylori/pathogenicity , Stomach Diseases/therapy , Antacids/therapeutic use , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacterial Vaccines/therapeutic use , Drug Resistance, Bacterial , Drug Therapy, Combination , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Helicobacter Infections/diagnosis , Helicobacter Infections/microbiology , Helicobacter Infections/transmission , Helicobacter pylori/drug effects , Helicobacter pylori/immunology , Humans , Hydrogen-Ion Concentration/drug effects , Probiotics/administration & dosage , Proton Pump Inhibitors/therapeutic use , Stomach Diseases/diagnosis , Stomach Diseases/microbiology , Treatment Outcome , Virulence Factors/metabolism
7.
Braz. J. Pharm. Sci. (Online) ; 55: e18204, 2019. tab, graf
Article in English | LILACS | ID: biblio-1039079

ABSTRACT

The development and clinical application of 2-methoxyestradiol (2-ME) as a new type of antitumor drug are limited due to its poor solubility, rapid metabolism in vivo, and large oral dosage. 2-ME-loaded pH-sensitive liposomes (2-ME-PSLs) was prepared containing the lipids, Lipoid E-80 (E-80), cholesteryl hemisuccinate (CHEMS), and cholesterol (CHOL) via thin-film ultrasonic dispersion. First, preparation conditions of 2-ME-PSLs were optimized by orthogonal test. Then 2-ME-PSL was characterized, and the release behavior and stability of 2-ME-PSL in vitro were evaluated. The optimal preparation conditions for 2-ME-PSLs were as follows: 2-ME : E-80+CHEMS 1:15; CHOL : E-80+CHEMS 1:5; ultrasonication time 20 minutes. The mean particle size, PDI, zeta potential, and entrapment efficiency (EE) of 2-ME-PSLs were 116 ± 9 nm, 0.161 ± 0.025, −22.4 ± 1.7 mV, and 98.6 ± 0.5%, respectively. As viewed under a transmission electron microscope, 2-ME-PSLs were well dispersed and almost spherical. They exhibited significant pH-sensitive properties and were fairly stable when diluted with a physiological solution. In conclusion, 2-ME-PSLs were successfully prepared and possessed a favorable pH sensitivity and good dissolution stability with a normal solution


Subject(s)
In Vitro Techniques/instrumentation , 2-Methoxyestradiol/pharmacokinetics , Liposomes/analysis , Drug Screening Assays, Antitumor/classification , Hydrogen-Ion Concentration/drug effects
8.
Braz. J. Pharm. Sci. (Online) ; 54(2): e00070, 2018. tab, graf
Article in English | LILACS | ID: biblio-951927

ABSTRACT

ABSTRACT The aim of the present study was to investigate the effect of donor pH on the transdermal permeability of the model drugs across rat skin and also to determine the major route of transport of the drugs. Weakly acidic drugs (partition coefficient) ibuprofen (3.6), aceclofenac (3.9), glipizide (1.9) and weakly basic drugs olanzapine (3.6), telmisartan (6.0), and sildenafil citrate (1.9) were selected for the study. The ex vivo permeation studies of these drugs at different donor pH (pH - 1.2, 4, 5, 6.8, 7.4, and 8) using Franz diffusion cell (area, 7.54 cm2) has shown a pH-dependent permeability. Among these drugs the weakly acidic drugs has shown higher permeation rates compared to the weakly basic drugs. The permeability coefficient and the distribution coefficient of the weakly basic drugs increased on increasing the pH whereas the weakly acidic drugs showed an inverse relation. The weakly basic drugs also showed an increase in permeation with increase in the fraction of unionized species indicating dominance of transcellular route of permeation. With an exception of sildenafil citrate, a weakly basic salt form of the drug which showed a high permeation value at pH 7.4 where 57% of the drug was unionized, indicating the involvement of both paracellular and transcellular route in its permeation.


Subject(s)
Animals , Male , Rats , Amino Acids, Acidic/analysis , Amino Acid Transport Systems, Basic/analysis , Hydrogen-Ion Concentration/drug effects , Skin , Solubility , Pharmaceutical Preparations/analysis
9.
Eur J Contracept Reprod Health Care ; 22(6): 407-411, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29250974

ABSTRACT

OBJECTIVES: The primary objective of our study was to ascertain whether moistening the Brazilian formulation of vaginal misoprostol tablets increases cervical dilation before manual vacuum aspiration (MVA), compared with use of dry misoprostol, in first-trimester miscarriage. The secondary objective was to ascertain whether there was any correlation between vaginal pH and the degree of cervical dilation using a moistened or dry misoprostol tablet. METHODS: In a single-centre, double-blind, randomised trial, 46 patients with first-trimester miscarriage were randomly allocated to treatment with dry or moistened (with 200 µl distilled water) 2 × 200 µg misoprostol tablets. RESULTS: The median (range) cervical dilation in the wet and dry groups was 8 mm (6-12 mm) and 7 mm (5-10 mm), respectively (p = .06). The median time between misoprostol insertion and carrying out the procedure did not differ between the dry (406 min, range 180-550 min) and wet (448 min, range 180-526 min) groups (p = .1). No correlation was found between vaginal pH and cervical dilation using continuous data (p = .57; r= 0.08; 95% confidence interval -0.02, 0.3) or dichotomous data (pH ≤5/>5; cervical dilation ≥8 mm or <8 mm; p = .8). CONCLUSION: No difference was observed in cervical dilation between moistened and non-moistened misoprostol use prior to MVA.


Subject(s)
Abortifacient Agents, Nonsteroidal/administration & dosage , Abortion, Spontaneous/therapy , Misoprostol/administration & dosage , Vacuum Curettage , Wetting Agents/administration & dosage , Administration, Intravaginal , Adolescent , Adult , Cervix Uteri/drug effects , Double-Blind Method , Female , Humans , Hydrogen-Ion Concentration/drug effects , Middle Aged , Pregnancy , Pregnancy Trimester, First , Treatment Outcome , Vagina/chemistry , Vagina/drug effects , Vaginal Creams, Foams, and Jellies/administration & dosage , Young Adult
10.
J Endod ; 43(1): 131-134, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27939738

ABSTRACT

INTRODUCTION: The objective of the present study was to evaluate the in vitro antibiofilm activity and pH of calcium hydroxide associated with different nonsteroidal anti-inflammatory drugs (NSAIDs). METHODS: The groups analyzed were as follows: group 1, calcium hydroxide paste with propylene glycol; group 2, calcium hydroxide paste with propylene glycol + 5% diclofenac sodium; group 3, calcium hydroxide paste with propylene glycol + 5% ibuprofen; group 4, calcium hydroxide paste with propylene glycol + 5% ciprofloxacin; and group 6, positive control (without medication). For analysis of the pH, the pastes were inserted into tubes and immersed in flasks containing ultrapure water. At the time intervals of 3, 24, 72, and 168 hours, the pH was measured with a calibrated pH meter. For microbial analysis, biofilm was induced in 30 bovine dentin blocks for 21 days. Subsequently, the pastes were placed on the blocks with biofilm for 7 days. Afterward, the pastes were removed by irrigation with sterile water, and the specimens were analyzed with a laser scanning confocal microscope with the 50 µL Live/Dead BacLight Bacterial Viability solution L7012 Kit (Molecular Probes, Inc, Eugene, OR). Data were subjected to statistical analysis at a significance level of 5%. RESULTS: The highest pH values were found for calcium hydroxide associated with ciprofloxacin in all periods analyzed. With the exception of pure calcium hydroxide paste, the other groups showed statistically significant differences (P < .05) in comparison with the positive control. CONCLUSIONS: The association of NSAIDs or antibiotic did not interfere with the pH of calcium hydroxide paste and increased the antimicrobial action of calcium hydroxide paste against Enterococcus faecalis biofilm formation.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Biofilms/drug effects , Calcium Hydroxide/therapeutic use , Dental Cements/therapeutic use , Enterococcus faecalis/drug effects , Anti-Bacterial Agents/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Diclofenac/administration & dosage , Diclofenac/therapeutic use , Drug Therapy, Combination , Enterococcus faecalis/growth & development , Hydrogen-Ion Concentration/drug effects , In Vitro Techniques
11.
Pflugers Arch ; 469(2): 251-261, 2017 02.
Article in English | MEDLINE | ID: mdl-28013412

ABSTRACT

Cellular energetic deregulation is widely known to produce an overproduction of acidic species in cancer cells. This acid overload must be counterbalanced with a high rate of H+ extrusion to maintain cell viability. In this sense, many H+ transporters have been reported to be crucial for cell survival and proposed as antineoplastic target. By the way, voltage-gated proton channels (Hv1) mediate highly selective H+ outward currents, capable to compensate acid burden in brief periods of time. This structure is canonically described acting as NADPH oxidase counterbalance in reactive oxygen species production. In this work, we show, for the first time in a oncohematologic cell line, that inhibition of Hv1 channels by Zn2+ and the more selective blocker 2-(6-chloro-1H-benzimidazol-2-yl)guanidine (ClGBI) progressively decreases intracellular pH in resting conditions. This acidification is evident minutes after blockade and progresses under prolonged exposure (2, 17, and 48 h), and we firstly demonstrate that this is followed by cell death through apoptosis (annexin V binding). Altogether, these results contribute strong evidence that this channel might be a new therapeutic target in cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Death/drug effects , Ion Channels/antagonists & inhibitors , T-Lymphocytes/drug effects , Cell Line , Cell Survival/drug effects , Humans , Hydrogen-Ion Concentration/drug effects , Ion Channel Gating/drug effects , Ion Channels/metabolism , Jurkat Cells , NADPH Oxidases/metabolism , Protons , Reactive Oxygen Species/metabolism , T-Lymphocytes/metabolism , Zinc/pharmacology
12.
Caries Res ; 50(5): 462-470, 2016.
Article in English | MEDLINE | ID: mdl-27577928

ABSTRACT

This study investigated the isolated and combined effect of a single application of TiF4 or NaF varnish versus daily use of a solution containing a low concentration of TiF4/NaF against tooth erosion in vitro. A total of 90 bovine enamel and 108 root dentin samples were treated as follows: control (no treatment), solution containing TiF4/NaF (500 ppm F-, pH 4.4), NaF varnish (24,500 ppm F-, pH 5.0), TiF4 varnish (24,500 ppm F-, pH 1.0), TiF4 varnish + solution, and NaF varnish + solution. The erosive challenges were performed 4 × 90s/day (0.1% citric acid, pH 2.5) and, between them, the samples were immersed in artificial saliva. The tooth loss was measured using contact profilometry (after 7 days for dentin and after 7, 10, and 14 days for enamel). All treatments were effective in reducing tooth loss, except NaF varnish for enamel on day 7 (p < 0.0001). TiF4/NaF solution and TiF4 varnish did not differ with respect to enamel loss for 10 days; thereafter, TiF4 varnish lost its protective effect compared to TiF4/NaF solution. The combination of vehicles was more effective in reducing enamel loss than both varnishes on their own but not compared to the solution. For dentin, TiF4 varnish was more effective than NaF varnish, while TiF4/NaF solution and NaF varnish were similar. The combination of vehicles improved the protective effect only when compared to NaF varnish on its own (p < 0.0001). Both types of TiF4 applications, isolated or combined, were effective against tooth erosion, but some differences in their performance were seen between enamel and dentin.


Subject(s)
Cariostatic Agents/pharmacology , Fluorides, Topical/pharmacology , Fluorides/pharmacology , Sodium Fluoride/pharmacology , Titanium/pharmacology , Tooth Erosion/prevention & control , Analysis of Variance , Animals , Cattle , Citric Acid/adverse effects , Dental Enamel/drug effects , Dentin/drug effects , Humans , Hydrogen-Ion Concentration/drug effects , Microscopy, Electron, Scanning , Saliva, Artificial/pharmacology , Spectrometry, X-Ray Emission , Time Factors , Tooth Erosion/chemically induced , Tooth Erosion/diagnostic imaging , Treatment Outcome
13.
Menopause ; 23(7): 792-8, 2016 07.
Article in English | MEDLINE | ID: mdl-27116462

ABSTRACT

OBJECTIVE: Vaginal atrophy is a common chronic condition among postmenopausal women that can affect their quality of life. Recent studies have evaluated new treatment alternatives for vaginal atrophy; however, few therapeutic options have been thoroughly evaluated. This study aimed to compare the effectiveness and adverse effects of estrogen, testosterone, polyacrylic acid, and placebo lubricant for the treatment of postmenopausal women with vaginal atrophy. METHODS: We conducted a randomized clinical trial with 80 postmenopausal women aged between 40 and 70 years who were being followed up at the Menopause Clinic of CAISM UNICAMP between November 2011 and January 2013. Women were randomly assigned to topical vaginal treatment with estrogen, testosterone, polyacrylic acid, and placebo lubricant, three times a week for 12 weeks. We used the vaginal maturation index, pH, vaginal health score, vaginal flora, laboratory tests, and ultrasound to evaluate changes of vaginal atrophy at baseline and after 6 and 12 weeks of treatment. RESULTS: After a 12-week treatment with topical estrogen and testosterone compared with the lubricant, an increased percentage of participants had vaginal pH less than 5, increased vaginal score, and an increase in the number of lactobacilli. Treatment with topical estrogen improved the vaginal maturation index and showed increased levels of estradiol in three women. No changes were observed in the endometrial evaluation of all treatment groups. CONCLUSIONS: After a 12-week treatment with testosterone and estrogen compared with placebo lubrication, there was a significant improvement in vaginal trophism in postmenopausal women with vaginal atrophy.


Subject(s)
Acrylic Resins/administration & dosage , Estrogens, Conjugated (USP)/administration & dosage , Estrogens/administration & dosage , Testosterone Propionate/administration & dosage , Vagina/pathology , Vaginal Diseases/drug therapy , Administration, Intravaginal , Adult , Aged , Atrophy/drug therapy , Female , Humans , Hydrogen-Ion Concentration/drug effects , Intention to Treat Analysis , Middle Aged , Postmenopause , Single-Blind Method , Treatment Outcome , Vagina/drug effects , Vaginal Creams, Foams, and Jellies/administration & dosage , Vaginal Diseases/pathology
14.
Peptides ; 78: 11-6, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26806200

ABSTRACT

We show here that crotamine, a polypeptide from the South American rattlesnake venom with cell penetrating and selective anti-fungal and anti-tumoral properties, presents a potent anti-plasmodial activity in culture. Crotamine inhibits the development of the Plasmodium falciparum parasites in a dose-dependent manner [IC50 value of 1.87 µM], and confocal microscopy analysis showed a selective internalization of fluorescent-labeled crotamine into P. falciparum infected erythrocytes, with no detectable fluorescence in uninfected healthy erythrocytes. In addition, similarly to the crotamine cytotoxic effects, the mechanism underlying the anti-plasmodial activity may involve the disruption of parasite acidic compartments H(+) homeostasis. In fact, crotamine promoted a reduction of parasites organelle fluorescence loaded with the lysosomotropic fluorochrome acridine orange, in the same way as previously observed mammalian tumoral cells. Taken together, we show for the first time crotamine not only compromised the metabolism of the P. falciparum, but this toxin also inhibited the parasite growth. Therefore, we suggest this snake polypeptide as a promising lead molecule for the development of potential new molecules, namely peptidomimetics, with selectivity for infected erythrocytes and ability to inhibit the malaria infection by its natural affinity for acid vesicles.


Subject(s)
Antimalarials/pharmacology , Cell-Penetrating Peptides/pharmacology , Crotalid Venoms/pharmacology , Plasmodium falciparum/drug effects , Snake Venoms/chemistry , Acridine Orange/metabolism , Amino Acid Sequence , Animals , Antimalarials/isolation & purification , Biological Transport , Carbocyanines/chemistry , Cell-Penetrating Peptides/isolation & purification , Cells, Cultured , Chloroquine/pharmacology , Crotalid Venoms/isolation & purification , Crotalus/metabolism , Dose-Response Relationship, Drug , Erythrocytes/drug effects , Erythrocytes/parasitology , Fluorescent Dyes/chemistry , Humans , Hydrogen-Ion Concentration/drug effects , Inhibitory Concentration 50 , Plasmodium falciparum/growth & development , Plasmodium falciparum/metabolism , Staining and Labeling , Vacuoles/drug effects , Vacuoles/parasitology
15.
Metallomics ; 7(7): 1173-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25966022

ABSTRACT

Streptococcus pneumoniae is a human pathogen whose principal virulence factor is its capsule. This structure allows the bacterium to evade the human immune system. Treatment of infections caused by this bacterium is based on antibiotics; however, the emergence of antibiotic-resistant strains makes this task increasingly difficult. Therefore, it is necessary to investigate new therapies, such as those based on gold nanoparticles, for which unfortunately the mechanisms involved have not yet been investigated. As far as we know, this study is the first that attempts to explain how gold nanoparticles destroy the bacterium Streptococcus pneumoniae. We found that the mean particle size was an important issue, and that the effect on the bacterium was dose-dependent. Cellular growth was inhibited by the presence of the nanoparticles, as was cell viability. The pH of the bacterial growth media was acidified, but interestingly the reactive species were not affected. A transmission electron microscopy analysis revealed the presence of inclusion bodies of gold nanoparticles within the bacterium. We present the first findings that attempt to explain how gold nanoparticles lyse Gram-positive bacteria.


Subject(s)
Gold/chemistry , Gold/pharmacology , Metal Nanoparticles/chemistry , Streptococcus pneumoniae/drug effects , Humans , Hydrogen-Ion Concentration/drug effects , Metal Nanoparticles/ultrastructure , Pneumococcal Infections/drug therapy , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/cytology , Streptococcus pneumoniae/growth & development
16.
Neuroscience ; 297: 194-204, 2015 Jun 25.
Article in English | MEDLINE | ID: mdl-25838118

ABSTRACT

Parkinson's disease (PD) is a neurodegenerative disease characterized by loss of the dopaminergic nigrostriatal pathway. In addition to deficits in voluntary movement, PD involves a disturbance of breathing regulation. However, the cause and nature of this disturbance are not well understood. Here, we investigated breathing at rest and in response to hypercapnia (7% CO2) or hypoxia (8% O2), as well as neuroanatomical changes in brainstem regions essential for breathing, in a 6-hydroxydopamine (6-OHDA) rat model of PD. Bilateral injections of 6-OHDA (24µg/µl) into the striatum decreased tyrosine hydroxylase (TH(+))-neurons in the substantia nigra pars compacta (SNpc), transcription factor phox2b-expressing neurons in the retrotrapezoid nucleus and neurokinin-1 receptors in the ventral respiratory column. In 6-OHDA-lesioned rats, respiratory rate was reduced at rest, leading to a reduction in minute ventilation. These animals also showed a reduction in the tachypneic response to hypercapnia, but not to hypoxia challenge. These results suggest that the degeneration of TH(+) neurons in the SNpc leads to impairment of breathing at rest and in hypercapnic conditions. Our data indicate that respiratory deficits in a 6-OHDA rat model of PD are related to downregulation of neural systems involved in respiratory rhythm generation. The present study suggests a new avenue to better understand the respiratory deficits observed in chronic stages of PD.


Subject(s)
Corpus Striatum/drug effects , Disease Models, Animal , Parkinson Disease/complications , Respiration Disorders/etiology , Adrenergic Agents/toxicity , Animals , Cell Count , Hydrogen-Ion Concentration/drug effects , Lactic Acid/blood , Locomotion/drug effects , Male , Neurons/drug effects , Neurons/metabolism , Oxidopamine/toxicity , Parkinson Disease/etiology , Psychomotor Performance , Pulmonary Ventilation/drug effects , Rats , Rats, Wistar , Receptors, Neurokinin-1/metabolism , Respiratory Center/drug effects , Respiratory Center/metabolism , Respiratory Center/pathology , Substantia Nigra/drug effects , Substantia Nigra/metabolism , Time Factors
17.
Braz Oral Res ; 292015.
Article in English | MEDLINE | ID: mdl-25715035

ABSTRACT

The addition of chlorhexidine (CHX) to a resinous experimental Mineral Trioxide Aggregate (E-MTA) based root-end filling material is an alternative to boost its antimicrobial activity. However, the influence of chlorhexidine on the properties of this material is unclear. The aim of this study was to evaluate the influence of 2% chlorhexidine on the pH, calcium ion release and setting time of a Bisphenol A Ethoxylate Dimethacrylate/Mineral Trioxide Aggregate (Bis-EMA/MTA) based dual-cure experimental root-end filling material (E-MTA), in comparison with E-MTA without the addition of CHX and with conventional white MTA (W-MTA). The materials were placed in polyethylene tubes, and immersed in deionized water to determine pH (digital pH meter) and calcium ion release (atomic absorption spectrometry technique). The setting time of each material was analyzed using Gilmore needles. The data were statistically analyzed at a significance level of 5%. E-MTA + CHX showed an alkaline pH in the 3 h period of evaluation, the alkalinity of which decreased but remained as such for 15 days. The pH of E-MTA + CHX was higher than the other two materials after 7 days, and lower after 30 days (p < 0.05). All of the materials were found to release calcium ions throughout the 30 days of the study. The addition of CHX increased the calcium ion release of E-MTA to levels statistically similar to W-MTA. E-MTA showed shorter initial and final setting time, compared with W-MTA (p < 0.05). The addition of 2% CHX to MTA prevented setting of the material. The addition of CHX to E-MTA increased its pH and calcium ion release. However, it also prevented setting of the material.


Subject(s)
Aluminum Compounds/chemistry , Calcium Compounds/chemistry , Calcium/chemistry , Chlorhexidine/chemistry , Methacrylates/chemistry , Oxides/chemistry , Root Canal Filling Materials/chemistry , Silicates/chemistry , Analysis of Variance , Drug Combinations , Hydrogen-Ion Concentration/drug effects , Immersion , Materials Testing , Reference Values , Statistics, Nonparametric , Time Factors
18.
Braz. oral res. (Online) ; 29(1): 1-6, 2015. tab
Article in English | LILACS | ID: lil-777231

ABSTRACT

The addition of chlorhexidine (CHX) to a resinous experimental Mineral Trioxide Aggregate (E-MTA) based root-end filling material is an alternative to boost its antimicrobial activity. However, the influence of chlorhexidine on the properties of this material is unclear. The aim of this study was to evaluate the influence of 2% chlorhexidine on the pH, calcium ion release and setting time of a Bisphenol A Ethoxylate Dimethacrylate/Mineral Trioxide Aggregate (Bis-EMA/MTA) based dual-cure experimental root-end filling material (E-MTA), in comparison with E-MTA without the addition of CHX and with conventional white MTA (W-MTA). The materials were placed in polyethylene tubes, and immersed in deionized water to determine pH (digital pH meter) and calcium ion release (atomic absorption spectrometry technique). The setting time of each material was analyzed using Gilmore needles. The data were statistically analyzed at a significance level of 5%. E-MTA + CHX showed an alkaline pH in the 3 h period of evaluation, the alkalinity of which decreased but remained as such for 15 days. The pH of E-MTA + CHX was higher than the other two materials after 7 days, and lower after 30 days (p < 0.05). All of the materials were found to release calcium ions throughout the 30 days of the study. The addition of CHX increased the calcium ion release of E-MTA to levels statistically similar to W-MTA. E-MTA showed shorter initial and final setting time, compared with W-MTA (p < 0.05). The addition of 2% CHX to MTA prevented setting of the material. The addition of CHX to E-MTA increased its pH and calcium ion release. However, it also prevented setting of the material.


Subject(s)
Aluminum Compounds/chemistry , Calcium Compounds/chemistry , Calcium/chemistry , Chlorhexidine/chemistry , Methacrylates/chemistry , Oxides/chemistry , Root Canal Filling Materials/chemistry , Silicates/chemistry , Analysis of Variance , Drug Combinations , Hydrogen-Ion Concentration/drug effects , Immersion , Materials Testing , Reference Values , Statistics, Nonparametric , Time Factors
19.
Rev. interdisciplin. estud. exp. anim. hum. (impr.) ; 6(único)dezembro 2014. graf, ilus, tab
Article in Portuguese | LILACS | ID: biblio-964724

ABSTRACT

O objetivo deste estudo, in vitro, foi analisar a variação do pH de três pastas à base de Ca(OH)2 e de cada um de seus componentes. Foram formados quatro grupos teste: GI: Ca(OH)2 + propilenoglicol (PG) + Aloe vera; GII: Ca(OH)2 + PG + paramonoclorofenol canforado (PMCC); GIII: Ca(OH)2 + PG + clorexidina 2% e grupo controle (água destilada). As pastas foram depositadas em frascos contendo 15 ml de água destilada e estes armazenados em estufa a 37° C. A mensuração do pH foi realizada em 7 intervalos de tempo. Os grupos testados apresentaram crescimento exponencial dos valores de pH registrados até 24 h e estabilização em 14 dias. Os controles apresentaram valores de pH inferiores em relação aos demais grupos (p<0,05 ­ ANOVA). A partir de t = 24 h, GII e GIII apresentaram maiores valores de pH em relação a GI (p<0,05 ­ Bonferroni). Numa segunda etapa, foram formados cinco grupos com os componentes individuais de cada pasta: GIc ­ clorexidina líquida 2%; GIIc ­ PG; GIIIc ­ PMCC; GIVc ­ hidróxido de cálcio P.A.; GVc ­ Aloe vera. GIVc e GVc apresentaram, respectivamente, os maiores e menores valores de pH registrados até o final do experimento (12,63 e 5,54). Conclui-se que o pH das pastas de Ca(OH)2 pode variar em função da sua composição, porém sempre se mantendo alcalino, mesmo quando associada à Aloe vera, cujo pH ácido foi registrado no presente estudo. No entanto, uma maior alcalinidade foi apresentada pelas pastas contendo clorexidina ou PMCC em sua composição.


The objective of this study, in vitro, was to analyze the variation of the pH of threeCa(OH)2 - based pastes and each of its components. There were four groups test: GI: Ca(OH)2 + propylene glycol (PG) + Aloe vera; GII: Ca(OH)2 + PG + camphorated paramonochlorophenol (CMCP); GIII: Ca(OH)2 + PG + 2% chlorhexidine and control group (distilled water). The pastes were deposited in vials containing 15 ml of distilled water and stored in a 37° C incubator. The measurement of pH was performed in 7 time intervals.The groups tested showed exponential growth of pH values recorded up to 24 h and stabilization in 14 days. The controls showed pH values lower than the other groups (p<0.05 ­ ANOVA). From t = 24 h, GII and GIII had higher levels of pH compared to GI (p<0.05 - Bonferroni). Subsequently, five groups were formed with the individual components of each paste: GIc - 2% chlorhexidine liquid; GIIc - PG; GIIIc - CMCP; GIVc - calcium hydroxide; GVc - Aloe vera. GIVc and GVc showed, respectively, the highest and lowest pH values recorded by the end of the experiment (12.63 and 5.54). It was concluded that the pH of Ca(OH)2 pastes may change depending on their composition, but always remained alkaline, even when associated with Aloe vera, whose acidic pH was recorded in this study. However, a higher alkalinity was presented by pastes containing chlorhexidine or CMCP in its composition.


Subject(s)
Calcium Hydroxide/analysis , Aloe , Hydrogen-Ion Concentration/drug effects , In Vitro Techniques , Endodontics , Phytotherapy
20.
Respir Physiol Neurobiol ; 190: 86-95, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-24035835

ABSTRACT

The locus coeruleus (LC) plays an important role in central chemoreception. In young rats (P9 or younger), 85% of LC neurons increase firing rate in response to hypercapnia vs. only about 45% of neurons from rats P10 or older. Carbenoxolone (CARB - gap junction blocker) does not affect the % of LC neurons responding in young rats but it decreases the % responding by half in older animals. We evaluated the participation of gap junctions in the CO2 ventilatory response in unanesthetized adult rats by bilaterally microinjecting CARB (300µM, 1mM or 3mM/100nL), glycyrrhizic acid (GZA, CARB analog, 3mM) or vehicle (aCSF - artificial cerebrospinal fluid) into the LC of Wistar rats. Bilateral gap junction blockade in LC neurons did not affect resting ventilation; however, the increase in ventilation produced by hypercapnia (7% CO2) was reduced by ∼25% after CARB 1mM or 3mM injection (1939.7±104.8mLkg(-1)min(-1) for the aCSF group and 1468.3±122.2mLkg(-1)min(-1) for 1mM CARB, P<0.05; 1939.7±104.8mLkg(-1)min(-1) for the aCSF group and 1540.9±68.4mLkg(-1)min(-1) for the 3mM CARB group, P<0.05) due largely to a decrease in respiratory frequency. GZA injection or CARB injection outside the LC (peri-LC) had no effect on ventilation under any conditions. The results suggest that gap junctions in the LC modulate the hypercapnic ventilatory response of adult rats.


Subject(s)
Gap Junctions/physiology , Locus Coeruleus/cytology , Respiration , Wakefulness/physiology , Analysis of Variance , Animals , Anti-Inflammatory Agents , Blood Gas Analysis , Carbenoxolone/pharmacology , Dose-Response Relationship, Drug , Gap Junctions/drug effects , Glycyrrhizic Acid/pharmacology , Hydrogen-Ion Concentration/drug effects , Hypercapnia/physiopathology , Locus Coeruleus/drug effects , Male , Microinjections , Rats , Rats, Wistar , Respiration/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL